4//SEC Filing
Leverone Jason A. 4
Accession 0001209191-20-019580
CIK 0001590750other
Filed
Mar 16, 8:00 PM ET
Accepted
Mar 17, 4:22 PM ET
Size
7.4 KB
Accession
0001209191-20-019580
Insider Transaction Report
Form 4
Leverone Jason A.
CFO, Treasurer & Secretary
Transactions
- Exercise/Conversion
Stock Option (right to buy)
2020-03-13−11,249→ 0 totalExercise: $0.57Exp: 2020-03-15→ Common Stock (11,249 underlying) - Exercise/Conversion
Common Stock
2020-03-13$0.57/sh+11,249$6,412→ 48,829 total
Footnotes (2)
- [F1]Includes 1,250 shares acquired under the Miragen Therapeutics, Inc. 2015 Employee Stock Purchase Plan on February 21, 2020.
- [F2]The option is fully vested and exercisable. The option expires ten years after the date of grant.
Documents
Issuer
MIRAGEN THERAPEUTICS, INC.
CIK 0001590750
Entity typeother
Related Parties
1- filerCIK 0001692747
Filing Metadata
- Form type
- 4
- Filed
- Mar 16, 8:00 PM ET
- Accepted
- Mar 17, 4:22 PM ET
- Size
- 7.4 KB